Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Majola is one of millions of patients in South Africa affected by U.S. President Donald Trump’s global foreign aid freeze, ...
Hosted on MSN4d
Trump funding pause threatens program to prevent spread of HIV and AIDS in over 50 countriesPresident Trump's executive action ordering a 90-day pause on foreign development aid threatens the program called the ...
The ripple effects of US President Donald Trump’s 90-day freeze of funding on foreign aid programmes have hit South Africa ...
Detailed price information for Theratechnologies Inc (THTX-Q) from The Globe and Mail including charting and trades.
Human immunodeficiency virus (HIV) is a virus that attacks the body's immune system. HIV is a manageable chronic condition. With treatment, people living with HIV can have long and healthy lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback